Sumanta Pal Highlights Review on Antibody Drug Conjugates in Urothelial Carcinoma
Sumanta Pal and Shilpa Gupta

Sumanta Pal Highlights Review on Antibody Drug Conjugates in Urothelial Carcinoma

Sumanta Pal, Professor and Vice Chair of Academic Affairs, City of Hope, shared on X by Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, adding:

“Absolutely loved this piece by Samer Salem, Kainat Warraich, and mentor Shilpa Gupta in the Journal of Clinical Oncology. A succinct but comprehensive overview of ADCs (past, present, and future) for bladder cancer. Perfect timing with the ongoing Bladder Cancer Advocacy Network meeting now!”

Quoting Shilpa Gupta:

“Thanks for the shout-out, Dr Yüksel Ürün.

Delighted to share our latest review in the ASCO Journal of Clinical Oncology, Oncology Practice.

On current evidence and practice considerations of ADCs in UC, in a truly explosive novel ADC era.”

Title: Antibody Drug Conjugates in Urothelial Carcinoma: Current Evidence and Practice Considerations

Authors: Samer Salem, Kainat Warraich, Shilpa Gupta

Read The Full Article.

Shilpa Gupta